![Ryu Ogawa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Ryu Ogawa
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Molcure, Inc.
![]() Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Director Ejecutivo | 01/05/2013 | - |
Fundador | 31/05/2013 | - |
Historial de carrera de Ryu Ogawa
Estadísticas
Internacional
Japón | 2 |
Operativa
Chief Executive Officer | 1 |
Founder | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Molcure, Inc.
![]() Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Ryu Ogawa
- Experiencia